
Résultats de la recherche - 105 results
Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay.
Results Uterine Cervical Neoplasms Abstract: The implementation of cervical screening based on human papillomavirus (HPV) continues to progress rapidly across countries. Evidence has shown that assays ...
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.
Uterine Cervical Neoplasms Abstract: In 2017, cervical cancer screening in the Netherlands switched from cytology to human papillomavirus (HPV) testing using the validated PCR-based cobas 4800. Women could ...
Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services
Publication Type: Peer reviewed scientific article Authors: Le Goff, Johane; Le Duc-Banaszuk, Anne-Sophie; Lefeuvre, Caroline; Pivert, Adeline; Ducancelle, Alexandra; H De Pauw; M. Arbyn; Vinay, Aubeline; Rexand-Galais, Franck Source: Cancers, Volume 15, ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
Kate; M. Arbyn Source: Journal of Medical Virology, Volume 95, Issue 1 (2023) Keywords: cervical cancer HPV genotyping human papillomavirus OncoPredict HPV® test validation. VALGENT Abstract: Human ...
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
papillomavirus (HPV) testing on self-samples represents a great opportunity to increase cervical cancer screening uptake among under-screened women. Methods A systematic review and meta-analysis on randomised ...
HPV and head and neck cancers: Towards early diagnosis and prevention.
viral infections, such as the mucosal high-risk (HR) human papillomaviruses (HPV s) are major risk factors for HNSCC development. In particular, HR HPV s are mainly associated with a subset of ...
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
Madhavan Radhakrishna; Sankaranarayanan, Rengaswamy; Bogers, Johannes; Pawlita, Michael; Tommasino, Massimo; M. Arbyn Source: BMC Infectious Diseases, Volume 22 (2022) Keywords: HPV DNA PCR; p16(INK4a) IHC; ...
Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework
clinically validated human papillomavirus (HPV) tests should be used in cervical cancer screening. VALGENT provides a framework to validate new HPV tests. In the VALGENT-3 study, the clinical accuracy of the ...
The European response to the WHO call cervical cancer as a public health problem
Issue 2 (2021) Keywords: cervical cancer screening COVID-19 elimination of cervical cancer Europe HPV vaccination WHO Abstract: The age‐standardised incidence of cervical cancer in Europe varies widely ...
HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
Madhavan Radhakrishna; Radhakrishna, Madhavan; Bogers, Johannes; Pawlita, Michael; Tommasino, Massimo; M. Arbyn; HPV-AHEAD study group Source: Cancer Epidemioly, Volume 72 (2021) Keywords: Adult Aged Aged, ...